Mixed outcomes from SSRI use in ACS patients
©Current Medicine Group Ltd However, it is notable that SSRIs additionally inhibit platelet activation, which may affect outcomes in ACS patients.
Patients with coronary artery disease often have anxiety, depression, and other related conditions, and SSRIs are commonly used to treat such conditions. MedWire News: The use of selective serotonin reuptake inhibitors (SSRIs) in patients hospitalized for a acute coronary syndrome (ACS) is known to be linked to reductions in the risk of recurrent ischemia, heart failure, and cardiac enzyme elevation, but it additionally leads to increased bleeding, US study findings indicate.
Original post by Anxiety Insights
No comments yet. Be the first.
Leave a reply



















